In the April–June 2016 edition of Corporate Disputes, Dr. Gregory K. Bell discusses disputes in the healthcare and life sciences industry. In this roundtable discussion, the panel experts describe the underlying causes of recent disputes in the sector and highlight key cases. To read the article, click the link below.
Supporting appropriate recognition and action for vaccination in AMR National Action Plans
Antimicrobial Resistance (AMR) is a serious and increasing threat to global health security and impacts the efficacy of medicines we have come to rely on, made...